ArticleFrontiers in immunology2026

Efgartigimod as a potential alternative to intravenous immunoglobulin in Guillain-Barré syndrome: a retrospective study.

Changyue Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.